Lea Cunningham

1.4k total citations
26 papers, 880 citations indexed

About

Lea Cunningham is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Lea Cunningham has authored 26 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Lea Cunningham's work include Acute Myeloid Leukemia Research (11 papers), Immune Cell Function and Interaction (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Lea Cunningham is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Immune Cell Function and Interaction (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Lea Cunningham collaborates with scholars based in United States, Switzerland and Canada. Lea Cunningham's co-authors include Raymond P. Wood, Z Yasruel, E Schotman, Qutayba Hamid, D LEUNG, Daniel L. Hamilos, Malcolm W. Klein, Cheryl L. Maxson, Chandrima Sinha and Paul Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Lea Cunningham

23 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lea Cunningham United States 11 322 228 205 176 170 26 880
Wolfgang Emminger Austria 15 243 0.8× 132 0.6× 85 0.4× 8 0.0× 41 0.2× 39 816
P Zanon Italy 17 121 0.4× 99 0.4× 410 2.0× 4 0.0× 208 1.2× 28 786
Christopher Thomas United States 13 24 0.1× 153 0.7× 43 0.2× 27 0.2× 31 0.2× 37 837
Risa Ebina‐Shibuya Japan 11 31 0.1× 163 0.7× 97 0.5× 9 0.1× 59 0.3× 25 679
WG Woods United States 15 937 2.9× 259 1.1× 20 0.1× 51 0.3× 29 0.2× 26 1.3k
Tom Révész Netherlands 17 680 2.1× 143 0.6× 24 0.1× 16 0.1× 17 0.1× 33 997
JF Apperley United Kingdom 16 963 3.0× 174 0.8× 26 0.1× 24 0.1× 9 0.1× 26 1.3k
Łukasz Wicherek Poland 18 27 0.1× 131 0.6× 33 0.2× 25 0.1× 42 0.2× 93 1.1k
JH Antin United States 8 644 2.0× 56 0.2× 14 0.1× 30 0.2× 6 0.0× 8 902
A. Robert Turner Canada 14 252 0.8× 237 1.0× 66 0.3× 3 0.0× 23 0.1× 33 850

Countries citing papers authored by Lea Cunningham

Since Specialization
Citations

This map shows the geographic impact of Lea Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Cunningham more than expected).

Fields of papers citing papers by Lea Cunningham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Cunningham. The network helps show where Lea Cunningham may publish in the future.

Co-authorship network of co-authors of Lea Cunningham

This figure shows the co-authorship network connecting the top 25 collaborators of Lea Cunningham. A scholar is included among the top collaborators of Lea Cunningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea Cunningham. Lea Cunningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trottier, Amy M., Lea Cunningham, & Lucy A. Godley. (2025). Hereditary Hematopoietic Malignancies: Considerations for Optimizing Diagnosis and Management. Current Oncology Reports. 27(8). 1019–1030.
2.
Yu, Kai, Natalie Deuitch, Lea Cunningham, et al.. (2023). Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy. Blood Advances. 8(2). 497–511. 9 indexed citations
3.
Khong, Yuet Mei, Jing Liu, Jack Cook, et al.. (2021). Harnessing formulation and clinical pharmacology knowledge for efficient pediatric drug development: Overview and discussions from M-CERSI pediatric formulation workshop 2019. European Journal of Pharmaceutics and Biopharmaceutics. 164. 66–74. 1 indexed citations
4.
Deuitch, Natalie, et al.. (2021). RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies. Europe PMC (PubMed Central). 7 indexed citations
5.
Sacco, Keith, et al.. (2021). Germline RUNX1 Deficiency Predisposes to Allergy and Autoimmunity. Journal of Allergy and Clinical Immunology. 147(2). AB68–AB68. 3 indexed citations
6.
Przepiorka, Donna, Lola Luo, Sriram Subramaniam, et al.. (2019). FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease. The Oncologist. 25(2). e328–e334. 91 indexed citations
7.
Koh, Kyung‐Nam, Anusha Sunkara, Guolian Kang, et al.. (2017). Acute Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes. Biology of Blood and Marrow Transplantation. 24(4). 758–764. 37 indexed citations
8.
Triplett, Brandon M., Guolian Kang, Shane J. Cross, et al.. (2017). Selective T‐cell depletion targeting CD45RA reduces viremia and enhances early T‐cell recovery compared with CD3‐targeted T‐cell depletion. Transplant Infectious Disease. 20(1). 40 indexed citations
9.
Sinha, Chandrima, et al.. (2017). Development and Evaluation of NK-CD123 CAR Against High Risk Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 23(3). S253–S253. 10 indexed citations
10.
Sinha, Chandrima & Lea Cunningham. (2016). An overview of the potential strategies for NK cell‐based immunotherapy for acute myeloid leukemia. Pediatric Blood & Cancer. 63(12). 2078–2085. 7 indexed citations
11.
12.
Sinha, Chandrima, Lea Cunningham, & Paul Liu. (2015). Core Binding Factor Acute Myeloid Leukemia: New Prognostic Categories and Therapeutic Opportunities. Seminars in Hematology. 52(3). 215–222. 30 indexed citations
13.
Goyama, Susumu, Lea Cunningham, Yue Zhang, et al.. (2013). Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. Journal of Clinical Investigation. 123(9). 3876–3888. 151 indexed citations
14.
Goyama, Susumu, Lea Cunningham, Yue Zhang, et al.. (2013). Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. Journal of Clinical Investigation. 123(11). 4979–4979. 5 indexed citations
15.
Marugán, Juan, Jingbo Xiao, Wei Zheng, et al.. (2013). ML223: A Small Molecule Probe With In Vivo Activity Against Acute Myeloid Leukemia Subtype M4Eo. 1 indexed citations
16.
Mussai, Francis, Lea Cunningham, Constantine A. Stratakis, et al.. (2008). Hypocalcemia in a Patient With Osteosarcoma and 22q11.2 Deletion Syndrome. Journal of Pediatric Hematology/Oncology. 30(8). 612–617. 6 indexed citations
17.
Cunningham, Lea & Richard Aplenc. (2007). Pharmacogenetics of acute lymphoblastic leukemia treatment response. Expert Opinion on Pharmacotherapy. 8(15). 2519–2531. 16 indexed citations
18.
Hamilos, Daniel L., D LEUNG, Raymond P. Wood, et al.. (1995). Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. Journal of Allergy and Clinical Immunology. 96(4). 537–544. 266 indexed citations
19.
Klein, Malcolm W., Cheryl L. Maxson, & Lea Cunningham. (1991). “CRACK,” STREET GANGS, AND VIOLENCE*. Criminology. 29(4). 623–650. 78 indexed citations
20.
Cunningham, Lea, H. Cottier, E. P. Cronkite, et al.. (1967). Studies on lymphocytes. Experimental Cell Research. 47(3). 479–488. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang Emminger Breakdown of academic impact, for papers by P Zanon Breakdown of academic impact, for papers by Christopher Thomas Breakdown of academic impact, for papers by Risa Ebina‐Shibuya Breakdown of academic impact, for papers by WG Woods Breakdown of academic impact, for papers by Tom Révész Breakdown of academic impact, for papers by JF Apperley Breakdown of academic impact, for papers by Łukasz Wicherek Breakdown of academic impact, for papers by JH Antin Breakdown of academic impact, for papers by A. Robert Turner
Rankless by CCL
2026